Zobrazeno 1 - 10
of 107
pro vyhledávání: '"Levent Doganay"'
Autor:
Nihat B. Agaoglu, Busra Unal, Connor P. Hayes, McKenzie Walker, Ozden Hatirnaz Ng, Levent Doganay, Nisan D. Can, Huma Q. Rana, Arezou A. Ghazani
Publikováno v:
Cancer Medicine, Vol 13, Iss 3, Pp n/a-n/a (2024)
Abstract Objective Turkish genome is underrepresented in large genomic databases. This study aims to evaluate the effect of allele frequency in the Turkish population in determining the clinical utility of germline findings in breast cancer, includin
Externí odkaz:
https://doaj.org/article/0e8c822e43624d2f9734ff8febc97f18
Autor:
Mustafa Zafer Temiz, Ibrahim Hacibey, Ramazan Omer Yazar, Mehmet Salih Sevdi, Suat Hayri Kucuk, Gizem Alkurt, Levent Doganay, Gizem Dinler Doganay, Muhammet Murat Dincer, Emrah Yuruk, Kerem Erkalp, Ahmet Yaser Muslumanoglu
Publikováno v:
Renal Failure, Vol 44, Iss 1, Pp 233-240 (2022)
Background Literature with regard to coronavirus disease 2019 (COVID-19) associated morbidities and the risk factors for death are still emerging. In this study, we investigated the presence of kidney damage markers and their predictive value for sur
Externí odkaz:
https://doaj.org/article/b8fa821e52ac45d898971f9cabea8f73
Autor:
Wen Zhong, Ozlem Altay, Muhammad Arif, Fredrik Edfors, Levent Doganay, Adil Mardinoglu, Mathias Uhlen, Linn Fagerberg
Publikováno v:
EBioMedicine, Vol 74, Iss , Pp 103723- (2021)
Background: COVID-19 has caused millions of deaths globally, yet the cellular mechanisms underlying the various effects of the disease remain poorly understood. Recently, a new analytical platform for comprehensive analysis of plasma protein profiles
Externí odkaz:
https://doaj.org/article/7164b72146b44fdc9e77d6fdcc3f62b6
Autor:
Suleyman Sayar, Kemal Kurbuz, Resul Kahraman, Roni Atalay, Oguzhan Ozturk, Zuhal Caliskan, Levent Doganay, Kamil Ozdil
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 7, Iss 1, Pp 49-55 (2020)
OBJECTIVE: There are many instruments to measure disease activity in ulcerative colitis. While determining clinical activity according to these instruments, many clinical and laboratory parameters are needed to be followed. Determination of disease a
Externí odkaz:
https://doaj.org/article/ea37cd9849cc4053a6e5bea64d17b0ce
Autor:
Ozlem Altay, Muhammad Arif, Xiangyu Li, Hong Yang, Mehtap Aydın, Gizem Alkurt, Woonghee Kim, Dogukan Akyol, Cheng Zhang, Gizem Dinler‐Doganay, Hasan Turkez, Saeed Shoaie, Jens Nielsen, Jan Borén, Oktay Olmuscelik, Levent Doganay, Mathias Uhlén, Adil Mardinoglu
Publikováno v:
Advanced Science, Vol 8, Iss 17, Pp n/a-n/a (2021)
Abstract COVID‐19 is associated with mitochondrial dysfunction and metabolic abnormalities, including the deficiencies in nicotinamide adenine dinucleotide (NAD+) and glutathione metabolism. Here it is investigated if administration of a mixture of
Externí odkaz:
https://doaj.org/article/b932227903334fd089c994a3da7f40a6
Autor:
Levent Doganay, Nihat Bugra Agaoglu, Arzu Irvem, Gizem Alkurt, Jale Yildiz, Betsi Kose, Yasemin Kendir, Ozlem Akgun Dogan, Gizem Dinler Doganay
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 7, Iss 3, Pp 311-312 (2020)
NCI-2020-0130
Externí odkaz:
https://doaj.org/article/fa3278c4d5464a7bbfd02021d6782dfd
Autor:
Levent Doganay, Kamil Ozdil, Kemal Memisoglu, Seyma Katrinli, Emre Karakoc, Emrah Nikerel, Gizem Dinler Doganay
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 4, Iss 1, Pp 1-3 (2017)
Externí odkaz:
https://doaj.org/article/24d3be707bc540bba38cebe9f4cce9fe
Publikováno v:
İstanbul Kuzey Klinikleri, Vol 5, Iss 2, Pp 169-170 (2018)
Externí odkaz:
https://doaj.org/article/e3555d9a6b7c4ab19c1aac42c9b545e4
Autor:
Hong Yang, Xiangyu Li, Han Jin, Hasan Turkez, Gurkan Ozturk, Hamdi Levent Doganay, Cheng Zhang, Jens Nielsen, Mathias Uhlén, Jan Borén, Adil Mardinoglu
Publikováno v:
Free Radical Biology and Medicine.
Growing evidence suggests that the depletion of plasma NAD+ and glutathione (GSH) may play an important role in the development of metabolic disorders. The administration of Combined Metabolic Activators (CMA), consisting of GSH and NAD+ precursors,
Autor:
Pinar Gokcen, Fatih Guzelbulut, Gupse Adali, Ayca Gokce Degirmenci Salturk, Oguzhan Ozturk, Ozgur Bahadir, Emine Kanatsiz, Mevlut Kiyak, Kamil Ozdil, Hamdi Levent Doganay
Publikováno v:
World Journal of Gastroenterology. 28:665-674
Several risk scores have been developed to predict hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients. The majority of risk scores are based on pretreatment variables that are no longer considered risk factors for HCC developme